Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cholesterol drug
Podcast
Editas plans to target high cholesterol with gene editing
The company revealed its new lead program as a possible one-time treatment for high cholesterol.
Eric Sagonowsky
Sep 2, 2025 1:46pm
Merck's oral PCSK9 makes waves with 3rd phase 3 win
Sep 2, 2025 9:35am
Merck's oral PCSK9 inhibitor leader reduces cholesterol in ph. 3
Jun 9, 2025 9:00am
Verve posts clean PCSK9 editor profile, teeing up Lilly decision
Apr 14, 2025 7:00am
NewAmsterdam shares sign drug improves cardiovascular outcomes
Dec 10, 2024 8:48am
NewAmsterdam’s cholesterol ph. 3 hits, but disappoints investors
Nov 20, 2024 10:07am
